Opus Genetics, Inc.
IRD
$2.06
$0.073.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -131.92% | 4.44% | -15.31% | -632.74% | -235.34% |
| Total Depreciation and Amortization | -- | -- | -- | 233.33% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,237.92% | -106.82% | -152.16% | 3,719.33% | -57.97% |
| Change in Net Operating Assets | -45.92% | -743.24% | -174.43% | -83.70% | 115.53% |
| Cash from Operations | -20.02% | -40.83% | -57.35% | -263.54% | -70.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,048.90% | -100.00% | 157.93% | -100.00% | -91.68% |
| Repurchase of Common Stock | -- | -- | 14.29% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -575.73% | -327.27% | 23,226.23% | 73.26% | 2.83% |
| Cash from Financing | 1,186.97% | -41.17% | 761.32% | -102.30% | -93.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.21% | -62.78% | 443.44% | -177.43% | -301.31% |